Get Industry Insights. Simply.

Advanced Search

Top 10 manufacturers in Actinic Solar Keratosis Treatment Market

 
By Prof Researh
Updated 11:40:17 January 19, 2020


Prof Resear published a new Market report on Actinic Solar Keratosis Treatment Market. It present the largest 10 manufacruers in Actinic Solar Keratosis Treatment Market. The report is a professional and in-depth study on the current state of the global Actinic Solar Keratosis Treatment market with a focus on the Chinese market. The report provides key statistics on market of Actinic Solar Keratosis Treatment. It is a valuable source of guidance and direction for companies and individuals interested in Actinic Solar Keratosis Treatment industry.


.

3M Drug Delivery Systems

Ref A: E549BFA98140421DB28434F376871D0A Ref B: SJCEDGE0420 Ref C: 2020-01-19T15:40:03Z

Athenex Inc

Nov 08, 2019 · Athenex , Inc . is a biopharmaceutical company , which engages in the discovery, development and commercialization of novel therapies for the … Description Athenex , Inc ., a biopharmaceutical company , engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions in North... Corporate Profile Athenex is a global oncology focused biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, aiming to develop safer and more efficacious cancer medication.

CritiTech Inc

Ref A: B656D80B302841388D14F477AA75194B Ref B: SJCEDGE0411 Ref C: 2020-01-19T15:40:05Z

Foamix Pharmaceuticals Ltd

Ref A: 502B6861BC8A442C80FAF84FE37745B2 Ref B: SJCEDGE0218 Ref C: 2020-01-19T15:40:08Z

G&E Herbal Biotechnology Co Ltd

Ref A: 41F56E6E44F344B1931394A1D7BA1DA4 Ref B: SJCEDGE0419 Ref C: 2020-01-19T15:40:09Z

Galderma SA

Ref A: 1668C079E2714009A5AC40C14465B7F7 Ref B: SJCEDGE0413 Ref C: 2020-01-19T15:40:11Z

Laboratories Ojer Pharma SL

Ref A: E89C08E4DFFA49AB9542F87E6BDD4317 Ref B: SJCEDGE0222 Ref C: 2020-01-19T15:40:12Z

LEO Pharma A/S

Ref A: B1D2063B57804DD3B1FE1AB18A6F70E8 Ref B: SJCEDGE0213 Ref C: 2020-01-19T15:40:13Z

Novartis AG

Ref A: 85CC554F7C56432A97FD67B32DFF9845 Ref B: SJCEDGE0413 Ref C: 2020-01-19T15:40:14Z

Oncology Resea

Ref A: 886561BFE2F94DFBB62BFCC0DB28FE94 Ref B: SJCEDGE0411 Ref C: 2020-01-19T15:40:17Z

For More information, Please access Read the total report.